What makes a good AI logo? It’s a thorny question that every player in the current crop of leading AI companies has faced, since unlike an email app — which marries neatly with an envelope ...

I'm not on lean no more. And how does The Boy know about - yeah, nah, he's tapped in. Damn, that was hard." Last year, in ...

In our hands-on review, we found Wix to be a "lean, efficient, and fast service which will have you create your logo and customize it to your heart’s content". We also noted that "Wix’s wealth ...

Continuous improvement using Lean principles creates a better experience for students, faculty, staff, and other customers. It also engages the people who are doing the work in improving the work, ...

Earlier, in an exchange filing on October 7, the company said, "Pursuant to Regulation 30 of Listing Regulations, please find enclosed Press Release - “Wockhardt's another breakthrough ...

Drugmaker Wockhardt has approached the Drug Controller General of India (DCGI) seeking approvals for its fast-acting insulin analog, Aspart injection. The company’s Aspart insulin injection ...

Companies that try to apply traditional startup methodologies, like the lean startup approach, to deep-tech ventures may face surprising pitfalls as deep-tech projects often involve technologies ...

After Jaslok and Wockhardt hospitals, a nurse in Breach Candy has tested positive for the novel coronavirus.With this, around 53 nurses and eight doctors have been affected across city hospitals ...

Shares of Wockhardt Ltd jumped 4.32 per cent in Wednesday's trade to scale their one-year high value of Rs 1,127.25. The stock was last seen trading 1.71 per cent up at Rs 1,099. At this price ...

Drug firm Wockhardt has denied allegations regarding payment of rent by Carol Info Services and its connection with certain ...

Drug firm Wockhardt on Friday said the national drug regulator has accorded a favourable recommendation for its novel antibiotic developed for the treatment of community-acquired bacterial ...

Shares of Wockhardt are locked at upper circuit after the pharma company said on September 19 that one of its investigational drug - Zaynich - has successfully treated critically ill patients of ...